NEW YORK (GenomeWeb) – Mbio Diagnostics today announced a product development and licensing agreement with Roka Bioscience.

The partnership will join MBio's multiplex, point-of-care diagnostics technology with Roka's solutions for food safety testing. The agreement covers "certain exclusive and non-exclusive fields," the firms said in a statement. Boulder, Colorado-based MBio and Warren, New Jersey-based Roka said they will jointly carry out product development.

Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.